Crestor and Sirolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Crestor (rosuvastatin calcium) and Sirolimus (sirolimus). Common drug interactions include peripheral swelling among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Crestor and Sirolimus. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,761 Crestor users. Check the latest studies of Crestor.

What is Sirolimus?

Sirolimus has active ingredients of sirolimus. eHealthMe is studying from 11,823 Sirolimus users. Check the latest studies of Sirolimus.



On Jul, 08, 2026

49 people who take Crestor and Sirolimus together, and have interactions are studied.

Crestor and Sirolimus drug interactions.

What are the common drug interactions of Crestor and Sirolimus, by gender? *:

female:

  1. Peripheral swelling
  2. Swelling face
  3. Abdominal pain
  4. Back pain
  5. Infection
  6. Pyrexia (fever)
  7. Vomiting
  8. Aphthous ulcer (mouth ulcer)
  9. Asthenia (weakness)
  10. Conjunctivitis (pink eye)

male:

  1. Blood creatinine increased
  2. Dyspnoea (difficult or laboured respiration)
  3. Decreased appetite
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Fall
  7. Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Muscular weakness (muscle weakness)
  10. Pancreatitis (inflammation of pancreas)

What are the common drug interactions of Crestor and Sirolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Burning sensation
  3. Candida sepsis (candida in blood stream)
  4. Colitis (inflammation of colon)
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Cystitis haemorrhagic (blood in the urine and painful voiding)
  7. Cytomegalovirus infection
  8. Diarrhoea
  9. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  10. Gastrointestinal obstruction

40-49:

  1. Stent placement

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Generalised oedema (swelling all over the body)
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Pancreatitis (inflammation of pancreas)
  5. Bone marrow transplant rejection
  6. Death
  7. Low density lipoprotein increased (cholesterol increased in blood)
  8. Oedema peripheral (superficial swelling)
  9. Pruritus (severe itching of the skin)
  10. Pulmonary oedema (fluid accumulation in the lungs)

60+:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Diarrhoea
  3. Swelling
  4. Drug ineffective
  5. Abdominal pain
  6. Arthralgia (joint pain)
  7. Back pain
  8. Brain natriuretic peptide increased
  9. Dyspnoea (difficult or laboured respiration)
  10. Dyspnoea exertional (breathlessness or shortness of breath)

What are the existing conditions these people have? *

  1. High Blood Pressure: 11 people, 22.45%
  2. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 8 people, 16.33%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 12.24%
  4. Immunodeficiency Disorders: 5 people, 10.20%
  5. Diabetes: 5 people, 10.20%
  6. Oedema (fluid collection in tissue): 4 people, 8.16%
  7. Lymphangioleiomyomatosis (a rare lung condition that affects a certain type of muscle cell and only occurs in women): 4 people, 8.16%
  8. Blood Pressure Abnormal: 4 people, 8.16%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 6.12%
  10. Cellulitis (infection under the skin): 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Crestor and Sirolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Crestor and Sirolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sirolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Crestor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sirolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium and sirolimus (the active ingredients of Crestor and Sirolimus, respectively), and Crestor and Sirolimus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: